or Try an Advanced Search...

    Technical Analysis for ANVS - Annovis Bio, Inc.

    Grade Last Price % Change Price Change
    F 5.27 -8.51% -0.49
    ANVS closed down 8.51 percent on Monday, July 1, 2024, on 59 percent of normal volume.
    3 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical ANVS trend table...
    Date Alert Name Type % Chg
    Wide Bands Range Expansion 0.00%
    Gapped Up Strength 0.00%
    20 DMA Resistance Bearish -8.51%
    20 DMA Resistance Bearish -12.17%
    Outside Day Range Expansion -12.17%
    NR7 Range Contraction -8.03%
    Narrow Range Bar Range Contraction -8.03%
    Inside Day Range Contraction -8.03%
    20 DMA Resistance Bearish -13.46%
    Wide Bands Range Expansion -13.46%
    Older End-of-Day Signals for ANVS ...

       Recent Intraday Alerts

    Alert Time
    Down 5% about 5 hours ago
    Fell Below Previous Day's Low about 6 hours ago
    Possible Inside Day about 6 hours ago
    Down 3% about 7 hours ago
    Down 2 % about 8 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    ANVS Chart by TradingView
    Basic chart:

    Profile

    Annovis Bio, Inc. develops drugs for Alzheimer's and Parkinson's diseases and other neurodegenerative disorders. It offers posiphen compound for mild cognitive impairment and early stage Alzheimer's disease and bisnorcymserine compound that inhibits amyloid formation and prevents the progression of the Alzheimer's disease. The company was founded by Maria Luisa Maccecchini in May 2008 and is headquartered in Berwyn, PA.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Organ Systems Alzheimer's Disease Parkinson's Disease Psychiatric Diagnosis Amyloid Nervous System Neurodegeneration Neurodegenerative Disorders Cognitive Disorders Cognitive Impairment Learning Disabilities Neuroprotection Early Stage Alzheimer's Disease Gladstone Institutes

    Is ANVS a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 30 Annovis: Strong Sell Reiteration Prior To Phase 3 Data In Parkinson's Disease
    Jun 28 Merck's (MRK) New Pneumococcal Jab Capvaxive Gets CDC Panel Vote
    Jun 27 CASI Pharmaceuticals (CASI) Up on Buyout Offer for China Business
    Jun 27 Annovis Bio files patent for new manufacturing process of buntanetap
    Jun 27 Annovis Bio Files Provisional Patent for New Manufacturing Process of Crystalline Form of Buntanetap
    Jun 26 ImmunityBio (IBRX) Gains 17% in the Past Week: Here's Why
    Jun 26 Annovis Bio Files Patent for New Composition of Matter for Buntanetap
    Jun 25 Annovis Bio Inc. (NYSE: ANVS) Schedules Investor Webcast to Discuss Parkinson’s Disease Data
    Jun 18 Annovis Bio Highlights New Alzheimer’s Data at the Alzheimer’s Association International Conference® 2024
    Jun 11 Annovis Bio’s Buntanetap Found Safe and Effective in High-Risk Alzheimer's Patients
    See more ANVS news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 22.49
    52 Week Low 4.79
    Average Volume 618,588
    200-Day Moving Average 9.30
    50-Day Moving Average 7.22
    20-Day Moving Average 6.07
    10-Day Moving Average 5.72
    Average True Range 0.73
    RSI (14) 39.76
    ADX 9.34
    +DI 16.84
    -DI 21.81
    Chandelier Exit (Long, 3 ATRs) 5.30
    Chandelier Exit (Short, 3 ATRs) 7.42
    Upper Bollinger Bands 7.01
    Lower Bollinger Band 5.13
    Percent B (%b) 0.07
    BandWidth 30.90
    MACD Line -0.46
    MACD Signal Line -0.49
    MACD Histogram 0.0344
    Fundamentals Value
    Market Cap 55.76 Million
    Num Shares 10.6 Million
    EPS -4.84
    Price-to-Earnings (P/E) Ratio -1.09
    Price-to-Sales 0.00
    Price-to-Book 17.40
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 6.35
    Resistance 3 (R3) 6.47 6.23 6.17
    Resistance 2 (R2) 6.23 5.95 6.17 6.11
    Resistance 1 (R1) 5.75 5.79 5.63 5.63 6.05
    Pivot Point 5.51 5.51 5.45 5.45 5.51
    Support 1 (S1) 5.03 5.23 4.91 4.91 4.49
    Support 2 (S2) 4.79 5.07 4.73 4.43
    Support 3 (S3) 4.31 4.79 4.37
    Support 4 (S4) 4.19